+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genomics Market 2024-2028

  • PDF Icon

    Report

  • 167 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5459502
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genomics market is forecasted to grow by USD 5.21 billion during 2023-2028, accelerating at a CAGR of 3.16% during the forecast period. The report on the genomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising investments in genomics research and development, a reduction in the cost of genetic sequencing, and an increasing need to create and upgrade genome databases.

The genomics market is segmented as below:

By Solution

  • Products
  • Services

By Application

  • Diagnostic
  • Drug discovery
  • Precision medicine and others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advances in sequencing technologies as one of the prime reasons driving the genomics market growth during the next few years. Also, growing developments in precision medicine and gene therapy and growing demand for direct-to-consumer genetic testing will lead to sizable demand in the market.

The report on the genomics market covers the following areas:

  • Genomics market sizing
  • Genomics market forecast
  • Genomics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market vendors that include 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc. Also, the genomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Solution
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global genomics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global genomics market 2018 - 2022 ($ billion)
4.2 Solution Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Solution Segment 2018 - 2022 ($ billion)
4.3 Application Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Solution
6.1 Market segments
Exhibit 30: Chart on Solution - Market share 2023-2028 (%)
Exhibit 31: Data Table on Solution - Market share 2023-2028 (%)
6.2 Comparison by Solution
Exhibit 32: Chart on Comparison by Solution
Exhibit 33: Data Table on Comparison by Solution
6.3 Products - Market size and forecast 2023-2028
Exhibit 34: Chart on Products - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Products - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Products - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Products - Year-over-year growth 2023-2028 (%)
6.4 Services - Market size and forecast 2023-2028
Exhibit 38: Chart on Services - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Services - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Services - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Services - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Solution
Exhibit 42: Market opportunity by Solution ($ billion)
Exhibit 43: Data Table on Market opportunity by Solution ($ billion)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2023-2028 (%)
Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Diagnostic - Market size and forecast 2023-2028
Exhibit 48: Chart on Diagnostic - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Diagnostic - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%)
7.4 Drug discovery - Market size and forecast 2023-2028
Exhibit 52: Chart on Drug discovery - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Drug discovery - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Drug discovery - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Drug discovery - Year-over-year growth 2023-2028 (%)
7.5 Precision medicine and others - Market size and forecast 2023-2028
Exhibit 56: Chart on Precision medicine and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Precision medicine and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Precision medicine and others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Precision medicine and others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Application
Exhibit 60: Market opportunity by Application ($ billion)
Exhibit 61: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 10X Genomics Inc.
Exhibit 111: 10X Genomics Inc. - Overview
Exhibit 112: 10X Genomics Inc. - Product / Service
Exhibit 113: 10X Genomics Inc. - Key offerings
12.4 Abcam plc
Exhibit 114: Abcam plc - Overview
Exhibit 115: Abcam plc - Product / Service
Exhibit 116: Abcam plc - Key news
Exhibit 117: Abcam plc - Key offerings
12.5 Agilent Technologies Inc.
Exhibit 118: Agilent Technologies Inc. - Overview
Exhibit 119: Agilent Technologies Inc. - Business segments
Exhibit 120: Agilent Technologies Inc. - Key offerings
Exhibit 121: Agilent Technologies Inc. - Segment focus
12.6 Becton Dickinson and Co.
Exhibit 122: Becton Dickinson and Co. - Overview
Exhibit 123: Becton Dickinson and Co. - Business segments
Exhibit 124: Becton Dickinson and Co. - Key news
Exhibit 125: Becton Dickinson and Co. - Key offerings
Exhibit 126: Becton Dickinson and Co. - Segment focus
12.7 BGI Group
Exhibit 127: BGI Group - Overview
Exhibit 128: BGI Group - Product / Service
Exhibit 129: BGI Group - Key offerings
12.8 Bio Rad Laboratories Inc.
Exhibit 130: Bio Rad Laboratories Inc. - Overview
Exhibit 131: Bio Rad Laboratories Inc. - Business segments
Exhibit 132: Bio Rad Laboratories Inc. - Key news
Exhibit 133: Bio Rad Laboratories Inc. - Key offerings
Exhibit 134: Bio Rad Laboratories Inc. - Segment focus
12.9 Danaher Corp.
Exhibit 135: Danaher Corp. - Overview
Exhibit 136: Danaher Corp. - Business segments
Exhibit 137: Danaher Corp. - Key news
Exhibit 138: Danaher Corp. - Key offerings
Exhibit 139: Danaher Corp. - Segment focus
12.10 Eppendorf SE
Exhibit 140: Eppendorf SE - Overview
Exhibit 141: Eppendorf SE - Product / Service
Exhibit 142: Eppendorf SE - Key news
Exhibit 143: Eppendorf SE - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Illumina Inc.
Exhibit 149: Illumina Inc. - Overview
Exhibit 150: Illumina Inc. - Business segments
Exhibit 151: Illumina Inc. - Key news
Exhibit 152: Illumina Inc. - Key offerings
Exhibit 153: Illumina Inc. - Segment focus
12.13 Myriad Genetics Inc.
Exhibit 154: Myriad Genetics Inc. - Overview
Exhibit 155: Myriad Genetics Inc. - Product / Service
Exhibit 156: Myriad Genetics Inc. - Key offerings
12.14 Oxford Nanopore Technologies plc
Exhibit 157: Oxford Nanopore Technologies plc - Overview
Exhibit 158: Oxford Nanopore Technologies plc - Product / Service
Exhibit 159: Oxford Nanopore Technologies plc - Key offerings
12.15 Pacific Biosciences of California Inc.
Exhibit 160: Pacific Biosciences of California Inc. - Overview
Exhibit 161: Pacific Biosciences of California Inc. - Product / Service
Exhibit 162: Pacific Biosciences of California Inc. - Key offerings
12.16 QIAGEN NV
Exhibit 163: QIAGEN NV - Overview
Exhibit 164: QIAGEN NV - Product / Service
Exhibit 165: QIAGEN NV - Key news
Exhibit 166: QIAGEN NV - Key offerings
12.17 Standard BioTools Inc.
Exhibit 167: Standard BioTools Inc. - Overview
Exhibit 168: Standard BioTools Inc. - Product / Service
Exhibit 169: Standard BioTools Inc. - Key news
Exhibit 170: Standard BioTools Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Solution
Exhibit 6: Executive Summary - Chart on Market Segmentation by Application
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global genomics market 2018 - 2022 ($ billion)
Exhibit 19: Historic Market Size - Solution Segment 2018 - 2022 ($ billion)
Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on Solution - Market share 2023-2028 (%)
Exhibit 31: Data Table on Solution - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by Solution
Exhibit 33: Data Table on Comparison by Solution
Exhibit 34: Chart on Products - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Products - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Products - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Products - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on Services - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Services - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Services - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Services - Year-over-year growth 2023-2028 (%)
Exhibit 42: Market opportunity by Solution ($ billion)
Exhibit 43: Data Table on Market opportunity by Solution ($ billion)
Exhibit 44: Chart on Application - Market share 2023-2028 (%)
Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
Exhibit 48: Chart on Diagnostic - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Diagnostic - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%)
Exhibit 52: Chart on Drug discovery - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Drug discovery - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Drug discovery - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Drug discovery - Year-over-year growth 2023-2028 (%)
Exhibit 56: Chart on Precision medicine and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Precision medicine and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Precision medicine and others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Precision medicine and others - Year-over-year growth 2023-2028 (%)
Exhibit 60: Market opportunity by Application ($ billion)
Exhibit 61: Data Table on Market opportunity by Application ($ billion)
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
Exhibit 107: Overview on factors of disruption
Exhibit 108: Impact of key risks on business
Exhibit 109: Vendors covered
Exhibit 110: Matrix on vendor position and classification
Exhibit 111: 10X Genomics Inc. - Overview
Exhibit 112: 10X Genomics Inc. - Product / Service
Exhibit 113: 10X Genomics Inc. - Key offerings
Exhibit 114: Abcam plc - Overview
Exhibit 115: Abcam plc - Product / Service
Exhibit 116: Abcam plc - Key news
Exhibit 117: Abcam plc - Key offerings
Exhibit 118: Agilent Technologies Inc. - Overview
Exhibit 119: Agilent Technologies Inc. - Business segments
Exhibit 120: Agilent Technologies Inc. - Key offerings
Exhibit 121: Agilent Technologies Inc. - Segment focus
Exhibit 122: Becton Dickinson and Co. - Overview
Exhibit 123: Becton Dickinson and Co. - Business segments
Exhibit 124: Becton Dickinson and Co. - Key news
Exhibit 125: Becton Dickinson and Co. - Key offerings
Exhibit 126: Becton Dickinson and Co. - Segment focus
Exhibit 127: BGI Group - Overview
Exhibit 128: BGI Group - Product / Service
Exhibit 129: BGI Group - Key offerings
Exhibit 130: Bio Rad Laboratories Inc. - Overview
Exhibit 131: Bio Rad Laboratories Inc. - Business segments
Exhibit 132: Bio Rad Laboratories Inc. - Key news
Exhibit 133: Bio Rad Laboratories Inc. - Key offerings
Exhibit 134: Bio Rad Laboratories Inc. - Segment focus
Exhibit 135: Danaher Corp. - Overview
Exhibit 136: Danaher Corp. - Business segments
Exhibit 137: Danaher Corp. - Key news
Exhibit 138: Danaher Corp. - Key offerings
Exhibit 139: Danaher Corp. - Segment focus
Exhibit 140: Eppendorf SE - Overview
Exhibit 141: Eppendorf SE - Product / Service
Exhibit 142: Eppendorf SE - Key news
Exhibit 143: Eppendorf SE - Key offerings
Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 149: Illumina Inc. - Overview
Exhibit 150: Illumina Inc. - Business segments
Exhibit 151: Illumina Inc. - Key news
Exhibit 152: Illumina Inc. - Key offerings
Exhibit 153: Illumina Inc. - Segment focus
Exhibit 154: Myriad Genetics Inc. - Overview
Exhibit 155: Myriad Genetics Inc. - Product / Service
Exhibit 156: Myriad Genetics Inc. - Key offerings
Exhibit 157: Oxford Nanopore Technologies plc - Overview
Exhibit 158: Oxford Nanopore Technologies plc - Product / Service
Exhibit 159: Oxford Nanopore Technologies plc - Key offerings
Exhibit 160: Pacific Biosciences of California Inc. - Overview
Exhibit 161: Pacific Biosciences of California Inc. - Product / Service
Exhibit 162: Pacific Biosciences of California Inc. - Key offerings
Exhibit 163: QIAGEN NV - Overview
Exhibit 164: QIAGEN NV - Product / Service
Exhibit 165: QIAGEN NV - Key news
Exhibit 166: QIAGEN NV - Key offerings
Exhibit 167: Standard BioTools Inc. - Overview
Exhibit 168: Standard BioTools Inc. - Product / Service
Exhibit 169: Standard BioTools Inc. - Key news
Exhibit 170: Standard BioTools Inc. - Key offerings
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
Exhibit 173: Currency conversion rates for US$
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
Exhibit 177: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global genomics market: 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advances in the sequencing technologies.'

According to the report, one of the major drivers for this market is the rising investments in genomics research and development.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 10X Genomics Inc.
  • Abcam plc
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • BGI Group
  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • Eppendorf SE
  • F. Hoffmann La Roche Ltd.
  • Hamilton Bonaduz AG
  • Illumina Inc.
  • Myriad Genetics Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California Inc.
  • Promega Corp.
  • QIAGEN NV
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc